Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page metadata was updated to revision v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-31T16:53:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A funding attribution line '2019 ( U.S. NIH Grant/Contract )' was added, indicating NIH support for the study.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:26.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    An updated site revision entry, v3.6.5, has been added, replacing the previous v3.6.4 in the revision history. This reflects a deployment or platform update rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-08-10T10:44:47.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays an updated site revision to v3.6.4, signaling a software patch applied to the ClinicalTrials.gov interface. This update represents an interface-level change rather than a modification to the study data.
    Difference
    0.0%
    Check dated 2026-07-27T06:22:48.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a minor UI/version update to the page rendering. It does not modify the study data or how the page operates.
    Difference
    0.0%
    Check dated 2026-07-05T13:47:18.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page, reflecting a minor version update to the site's rendering or functionality. This update does not alter study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-28T08:22:33.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.